This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) inched 0.13% higher to $7.54 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.16% to 4,473.75 and Dow Jones Industrial Average falling 0.18% to 34,751.32. The stock's rise snapped a two-day losing streak. Ocugen Inc. closed $11.23 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock underperformed when compared to some of its competitors Thursday, as Adverum Biotechnologies Inc. (ADVM) rose 2.76% to $2.23, Ocular Therapeutix Inc. (OCUL) rose 0.19% to $10.32, and Kodiak Sciences Inc. (KOD) rose 2.90% to $97.26. Trading volume (7.7 M) remained 6.4 million below its 50-day average volume of 14.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 16, 2021.
(END) Dow Jones Newswires
September 16, 2021 17:14 ET (21:14 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.